Heparin induced thrombocytopenia antibodies in Covid‐19
Open Access
- 13 July 2020
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 95 (10) , E295-E296
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infectionBlood, 2020
- Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19JACC, 2020
- Immune Thrombocytopenic Purpura in a Patient with Covid-19New England Journal of Medicine, 2020
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19New England Journal of Medicine, 2020
- Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL ® HIT-Ab (PF4-H) ] for the diagnosis of immune heparin-induced thrombocytopeniaThrombosis Research, 2017
- Heparin induced thrombocytopenia and thrombosis in a tertiary care hospitalThrombosis Research, 2009
- The Incidence of Recognized Heparin-Induced Thrombocytopenia in a Large, Tertiary Care Teaching HospitalChest, 2007